The detection and consequences of anxiety in clinical depression

Journal of Clinical Psychiatry

Volumn 58, Issue SUPPL. 8, 1997, Pages 35-40

  Fawcett, Jan ^a  

^a RUSH UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPRAZOLAM; HALOPERIDOL; IMIPRAMINE; NORTRIPTYLINE; TRAZODONE;

ANALYTIC METHOD; ANXIETY; COMORBIDITY; CONFERENCE PAPER; DEPRESSION; DISEASE SEVERITY; DRUG EFFICACY; HIGH RISK POPULATION; HUMAN; PRIORITY JOURNAL; RATING SCALE; RISK FACTOR; SUICIDE;

ADULT; ANTIDEPRESSIVE AGENTS, TRICYCLIC; ANXIETY DISORDERS; BENZODIAZEPINES; COMORBIDITY; DEPRESSIVE DISORDER; HUMANS; MALE; MIDDLE AGED; PSYCHOMOTOR AGITATION; RISK FACTORS; SEVERITY OF ILLNESS INDEX; SUICIDE;

EID: 0030795481     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (27)

1. Fawcett J, Kravitz HM. Anxiety syndromes and their relationship to depressive illness. J Clin Psychiatry 1983;44:8-11
2. Clayton PJ, Grove WM, Coryell W, et al. Follow-up and family study of anxious depression. Am J Psychiatry 1991;148:1512-1517
3. Joffe RT, Bagby M, Levin A. Anxious and nonanxious depression. Am J Psychiatry 1993;150:1257-1258
4. Coryell W, Endicott J, Andreasen NC, et al. Depression and panic attacks: the significance of overlap as reflected in follow-up and family study data. Am J Psychiatry 1988;145:293-300
5. Coryell W, Endicott J, Winokur G. Anxiety syndromes as epiphenomena of primary major depression: outcome and familial psychopathology. Am J Psychiatry 1992;149:100-107
6. Bech P, Allerup P. The Hamilton Depression Scale: evaluation of objectivity using logistic models. Acta Psychiatr Scand 1981;63:290-299
7. Gibbons RD, Clark DC, Kupfer DJ. Exactly what does the Hamilton Depression Rating Scale measure? J Psychiat Res 1993;27:259-273
8. Allebeck P, Allgulander C, Fisher LD. Predictors of completed suicide in a cohort of 50,465 young men: role of personality and deviant behaviour. BMJ 1988;297:176-178
9. Coryell W. Panic disorder and mortality. Psychiatr Clin North Am 1988; 11:433-440
10. Isometsä ET, Henriksson MM, Aro HM, et al. Suicide in major depression. Am J Psychiatry 1994;151:530-536
11. Fawcett J, Scheftner WA, Fogg L, et al. Time-related predictors of suicide in major affective disorder. Am J Psychiatry 1990;147:1189-1194
12. Busch KA, Clark DC, Fawcett J, et al. Clinical features of inpatient suicide. Psychiatr Ann 1993;23:256-262
13. Bunney WE, Fawcett JA. Possibility of a biochemical test for suicidal potential: an analysis of endocrine findings prior to three studies. Arch Gen Psychiatry 1965;13:232-239
14. Fawcett J, Busch KA. The psychobiology of suicide. Clin Neurosci 1993; 1:232-239
15. Åsberg M, Träskman L, Thorén P. 5-HIAA in the cerebrospinal fluid: a biochemical suicide predictor? Arch Gen Psychiatry 1976;33:1193-1197
16. Beigon A, Weizman A, Karp L, et al. Serotonin 5-HT2 receptor binding on blood platelets: a peripheral marker for depression? Life Sci 1987;41: 2485-2492
17. Pandey GN, Pandey SC, Dwivedi Y, et al. Platelet serotonin-2A receptors: a potential biological marker for suicidal behavior. Am J Psychiatry 1995; 152:850-855
18. Krieger G. Plasma level of cortisol as a predictor of suicide. Dis Nerv Syst 1974;35:237-240
19. Lester D. The dexamethasone suppression test as an indicator of suicide: a meta-analysis. Pharmacopsychiatry 1992;25:265-270
20. Sachar EJ, Kanter SS, Buie D, et al. Psychoendocrinology of ego disintegration. Am J Psychiatry 1970;126:1067-1078
21. Fawcett J, Marcus RN, Anton SF, et al. Response of anxiety and agitation symptoms during nefazodone treatment of major depression. J Clin Psychiatry 1995;56(suppl 6):37-42
22. Zubenko GS, Cohen BM, Lipinski JF. Antidepressant-related akathisia. J Clin Psychopharmacol 1987;7:254-257
23. Lipinski JF Jr, Mallya G, Zimmerman P, et al. Fluoxetine-induced akathisia: clinical and theoretical implications. J Clin Psychiatry 1989;50: 339-342
24. Wirshing WC, Van Putten T, Rosenberg J, et al. Fluoxetine, akathisia and suicidality: is there a causal connection? Arch Gen Psychiatry 1992;49: 580-581
25. Rothschild AJ, Locke CA. Reexposure to fluoxetine after serious suicide attempts by three patients: the role of akathisia. J Clin Psychiatry 1991;52:491-493
26. Nemeroff CB, Widerlov E, Bissette G, et al. Elevated concentrations of CSF corticotropin-releasing factor-like immunoreactivity in depressed patients. Science 1984;226:1342-1343
27. Owens MJ, Vargas MA, Knight DL, et al. The effects of alprazolam on corticotropin-releasing factor neurons in the rat brain: acute time course, chronic treatment and abrupt withdrawal. J Pharmacol Exp Ther 1991;258: 349-356